Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|11|1670-1676

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.11, 2014-06, pp. : 1670-1676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Aspects of the Treatment of Patients with Low-Risk Myelodysplastic Syndromes

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 12-16

Karger

Access to resources Recommend Favorite

Factors Influencing GPs' Decisions on the Treatment of Hypercholesterolaemic Patients

By Backlund Lars   Danielsson Birgitta   Bring Johan   Strender Lars-Erik  

Scandinavian Journal of Primary Health Care, Vol. 18, Iss. 2, 2000-10 ,pp. : 87-93

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin treatment in patients with myelodysplastic syndromes and type 2 diabetes 促红细胞生成素治疗骨髓增生异常综合征合并2型糖尿病的患者

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 4, 2015-07 ,pp. : 493-496

John Wiley & Sons Inc

Access to resources Recommend Favorite

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 104-107

Karger

Access to resources Recommend Favorite

Pharmacist and improvement adherence

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 21, Iss. 1, 2015-02 ,pp. : 7-12

John Wiley & Sons Inc

Access to resources Recommend Favorite